Live feed15:17:00·85dPRReleasevia QuantisnowPharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDSByQuantisnow·Wall Street's wire, on your screen.PHAR· Pharming Group N.V. ADS each representing 10Health Care